PMVP PMV Pharmaceuticals
- 1.820
- +0.030+1.68%
PMV Pharmaceuticals News
PMV Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Phathom Pharmaceuticals (PHAT)
PMV Pharma Analyst Ratings
PMV Pharma Analyst Ratings
Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target
Oppenheimer Remains a Hold on PMV Pharmaceuticals (PMVP)
PMV Pharma Analyst Ratings
PMV Pharmaceuticals: Buy Rating Affirmed Amid Strong Financials and Promising Clinical Prospects
Oppenheimer Keeps Their Hold Rating on PMV Pharmaceuticals (PMVP)
TD Cowen Reaffirms Their Buy Rating on PMV Pharmaceuticals (PMVP)
Ladenburg Thalmann Initiates Coverage On PMV Pharma With Buy Rating, Announces Price Target of $7
PMV Pharma Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aldeyra Therapeutics (ALDX), Amylyx Pharmaceuticals Inc (AMLX) and PMV Pharmaceuticals (PMVP)
TD Cowen Keeps Their Buy Rating on PMV Pharmaceuticals (PMVP)
PMV Pharmaceuticals Receives 'Buy' Rating Based on PYNNACLE Trial Results and Ongoing Cancer Research Progress
HC Wainwright & Co. Maintains Buy on PMV Pharma, Lowers Price Target to $5
PMV Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Centene (CNC), PMV Pharmaceuticals (PMVP) and Walgreens Boots Alliance (WBA)
Promising Prospects for PMV Pharmaceuticals: Buy Rating Bolstered by PC14586 Progress and Potential Accelerated Approval Pathway
Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP), Insulet (PODD) and RegenXBio (RGNX)
Analysis
Price Target
No Data
